SKP2 and hereditary pheochromocytoma-paraganglioma: For instance, decreasing SKP2 expression was also detected in older patients with BRCA (breast invasive carcinoma) and young patients with PCPG (pheochromocytoma and paraganglioma) (p < 0.05) (Supplementary Material 9).